-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – RCT-2100 in Cystic Fibrosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - RCT-2100 in Cystic Fibrosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. RCT-2100 in Cystic Fibrosis Drug Details: RCT-2100 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – RCT-1100 in Primary Ciliary Dyskinesia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - RCT-1100 in Primary Ciliary Dyskinesia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. RCT-1100 in Primary Ciliary Dyskinesia Drug Details: Oligonucleotide is under development...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Telitacicept in Relapsing Remitting Multiple Sclerosis (RRMS)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Telitacicept in Relapsing Remitting Multiple Sclerosis (RRMS) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Telitacicept in Relapsing Remitting Multiple Sclerosis (RRMS) Drug Details:...
-
Product Insights
NewPTA Peripheral DCB Catheters Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
PTA Peripheral DCB Catheters Pipeline Market Report Overview A PTA Peripheral DCB Catheter is a drug-coated percutaneous transluminal angioplasty (PTA) balloon intended to prevent restenosis or restenosis of the peripheral arteries. PTA Peripheral DCB catheters provide fast, short-term, homogenous, local drug delivery to the vessel wall while preserving the anatomy of the vessel, promoting enhanced vessel healing, and reducing the need for prolonged dual antiplatelet therapy. They can be used to treat native and in-stent restenosis (ISR), bifurcations, small vessels,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Telitacicept in IgA Nephropathy (Berger’s Disease)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Telitacicept in IgA Nephropathy (Berger's Disease) Drug Details: Telitacicept (Tai' ai) is a potential new...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Telitacicept in Systemic Lupus Erythematosus
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Telitacicept in Systemic Lupus Erythematosus report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Telitacicept in Systemic Lupus Erythematosus Drug Details: Telitacicept (Tai' ai) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Telitacicept in Antiphospholipid Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Telitacicept in Antiphospholipid Syndrome report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Telitacicept in Antiphospholipid SyndromeDrug Details:Telitacicept (Tai' ai) is a potential new TACI-Fc fusion...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Telitacicept in Relapsing Remitting Multiple Sclerosis (RRMS)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Telitacicept in Relapsing Remitting Multiple Sclerosis (RRMS) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Telitacicept in Relapsing Remitting Multiple Sclerosis (RRMS) Drug Details:Telitacicept (Tai'...
-
Product Insights
Drug Eluting Stents (DES) Pipeline by Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies
Drug Eluting Stents (DES) Pipeline Market Report Overview Drug eluting stents (DES) release drugs locally and can be coated with a polymeric material. The Drug Eluting Stents (DES) pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials. Key...
-
Product Insights
Clot Management Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Clot Management Devices Pipeline Market Report Overview Clot Management Devices are used for the removal or dissolution of a clot from a blood vessel to restore proper blood circulation. This device is used as a routine procedure while performing percutaneous coronary intervention and for treating potentially life-threatening complications. The clot management devices pipeline market research report provides comprehensive information on the products with their comparative segment-wise analysis in various stages of development. The report also covers the regional and country-wise...